bioRxivPharmacology & Toxicology
Impulse initiation in engrafted pluripotent stem cell-derived cardiomyocytes can stimulate the recipient heart.
T. Stuedemann, B. Schwarzova, T. Schneidewind, B. Geertz, C. von Bibra, M. Nehring, J. Roessinger, J. S. Wiegert, T. Eschenhagen, F. Weinberger
Abstract
Transplantation of pluripotent stem cell-derived cardiomyocytes is a novel promising cell-based therapeutic approach for patients with heart failure. However, engraftment arrhythmias are a predictable life-threatening complication and represent a major hurdle for clinical translation. Catheter-based electrophysiological analysis suggested that the ventricular arrhythmias were caused by an automaticity of the transplanted cells, but whether impulse generation by transplanted cardiomyocytes can propagate to the host myocardium and override the recipient rhythm has not been directly assessed experimentally. We used optogenetics to specifically activate engrafted cardiomyocytes, which resulted in impulse generation in the engrafted cardiomyocytes and stimulated the recipient heart (4/9 hearts). Thus, our study shows that transplanted cardiomyocytes can electrically couple to the host myocardium and stimulate the recipient heart, providing experimental evidence that cardiomyocyte automaticity can serve as a trigger for ventricular arrhythmias.
- organism: mouse
- assay: electrophysiology
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cellular Heterogeneity of Pluripotent Stem Cell Derived Cardiomyocyte Grafts is Mechanistically Linked to Treatable Arrhythmias
D. Selvakumar, Z. E. Clayton, … J. J. H. Chong·bioRxiv·Sep 15, 2022
- Human iPSC-derived Committed Cardiac Progenitors Generate Cardiac Tissue Grafts in a Swine Ischemic Cardiomyopathy Model without Triggering Ventricular Arrhythmias
A. N. Raval, E. G. Schmuck, … T. J. Kamp·bioRxiv·Feb 14, 2024
- Pharmacologic Therapy for Engraftment Arrhythmia Induced by Transplantation of Human Cardiomyocytes
K. Nakamura, L. E. Neidig, … C. E. Murry·Stem Cell ReportsPeer-reviewed·Oct 1, 2021
- Contractile force of transplanted cardiomyocytes contributes to heart function after injury
T. Stuedemann, J. Roessinger, … F. Weinberger·bioRxiv·Nov 23, 2021
- In situ maturated early-stage human induced pluripotent stem cell-derived cardiomyocytes improve cardiac function by enhancing segmentary contraction in infarcted rats
D. Biagi, E. T. Fantozzi, … R. Dariolli·bioRxiv·Mar 9, 2021
- Phase resetting in human stem cell derived cardiomyocytes explains complex cardiac arrhythmias
Khady Diagne, Thomas M. Bury, … Emilia G. Entcheva·PLoS Computational BiologyPeer-reviewed·Feb 4, 2026